Artwork

Innhold levert av Savills. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Savills eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
Gå frakoblet med Player FM -appen!

What can we expect from the UK life science sector as it continues to mature?

21:03
 
Del
 

Manage episode 345959758 series 3257599
Innhold levert av Savills. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Savills eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

Life science remains a hot topic for many within real estate, with a number of new entrants looking to break into the UK market as the sector continues to mature. However, with the current funding landscape impacted by wider macro-economics, and more hesitancy from those looking to invest, it is important to stress that the fundamentals remain strong.
Join Guy Ruddle and guests, Tom Mellows, Savills head of UK science, Olivia Drew, director and portfolio manager of UK life sciences at UBS and Freddie Dear, investment manager at Monograph Capital and head of corporate development at Ascend Gene & Cell Therapies, as they discuss what’s needed to meet the sector’s growing requirements.

  continue reading

155 episoder

Artwork
iconDel
 
Manage episode 345959758 series 3257599
Innhold levert av Savills. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Savills eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

Life science remains a hot topic for many within real estate, with a number of new entrants looking to break into the UK market as the sector continues to mature. However, with the current funding landscape impacted by wider macro-economics, and more hesitancy from those looking to invest, it is important to stress that the fundamentals remain strong.
Join Guy Ruddle and guests, Tom Mellows, Savills head of UK science, Olivia Drew, director and portfolio manager of UK life sciences at UBS and Freddie Dear, investment manager at Monograph Capital and head of corporate development at Ascend Gene & Cell Therapies, as they discuss what’s needed to meet the sector’s growing requirements.

  continue reading

155 episoder

Tutti gli episodi

×
 
Loading …

Velkommen til Player FM!

Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.

 

Hurtigreferanseguide

Copyright 2024 | Sitemap | Personvern | Vilkår for bruk | | opphavsrett